Stada Arzneimittel AG - Strategic SWOT Analysis Review

August 2021 | 40 pages | ID: S0AA5921B677EN
GlobalData

Abstracts

Stada Arzneimittel AG

Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Stada Arzneimittel AG (STADA), a subsidiary of Nidda Healthcare GmbH, is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers portfolio of products in various therapeutic categories including pain, women's health, cardiovascular conditions and diabetes. Few of its major generic products include including Tilidin Naloxon, Atorvastatin and Epoetin zeta. Its major branded products include APO-Go, Grippostad, Snup and Fultium. The company operates across Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. STADA is headquartered in Bad Vilbel, Germany.

Stada Arzneimittel AG Key Recent Developments

Jun 29,2021: STADA to acquire 16 consumer healthcare brands from Sanofi
Oct 05,2020: European Pharmaceutical Company STADA enters exclusive medical cannabis partnership with MediPharm Labs
Jul 01,2020: New name – proven strengths: STADA becomes STADA Consumer Health Deutschland
Jun 17,2020: STADA Health Report 2020: Europe demands compulsory vaccinations
Mar 03,2020: Dr. Stephan Eder is appointed as Executive Vice President of STADA Russia/CIS

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Stada Arzneimittel AG - Key Facts
Stada Arzneimittel AG - Key Employees
Stada Arzneimittel AG - Key Employee Biographies
Stada Arzneimittel AG - Major Products and Services
Stada Arzneimittel AG - History
Stada Arzneimittel AG - Company Statement
Stada Arzneimittel AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Stada Arzneimittel AG - Business Description
Product Category: Branded Products
Overview
Performance
Product Category: Generics
Overview
Performance
Geographical Segment: Belgium
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Russian Federation
Performance
Geographical Segment: The UK
Performance
R&D Overview
Stada Arzneimittel AG - Corporate Strategy
Stada Arzneimittel AG - SWOT Analysis
SWOT Analysis - Overview
Stada Arzneimittel AG - Strengths
Stada Arzneimittel AG - Weaknesses
Stada Arzneimittel AG - Opportunities
Stada Arzneimittel AG - Threats
Stada Arzneimittel AG - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Stada Arzneimittel AG, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Oct 05, 2020: European Pharmaceutical Company STADA enters exclusive medical cannabis partnership with MediPharm Labs
Jul 01, 2020: New name – proven strengths: STADA becomes STADA Consumer Health Deutschland
Jun 17, 2020: STADA Health Report 2020: Europe demands compulsory vaccinations
Mar 03, 2020: Dr. Stephan Eder is appointed as Executive Vice President of STADA Russia/CIS
Feb 25, 2020: STADA agrees to buy 15 consumer healthcare brands from GSK
Feb 25, 2020: Canon Medical to commence development of a rapid genetic testing system for the Novel Coronavirus (COVID-19)
Feb 10, 2020: Aidan Fry joins STADA’s corporate communications team
Jan 29, 2020: Wolfgang Ollig to become new CFO of the STADA Group

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Stada Arzneimittel AG, Key Facts
Stada Arzneimittel AG, Key Employees
Stada Arzneimittel AG, Key Employee Biographies
Stada Arzneimittel AG, Major Products and Services
Stada Arzneimittel AG, History
Stada Arzneimittel AG, Subsidiaries
Stada Arzneimittel AG, Key Competitors
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Stada Arzneimittel AG, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021